Source: Scientific Reports, written by Zaky A. Zaky; Ali Hennache; Abinash Panda (October 31, 2026). AI-generated summary by biochip.com, published . Not independently reviewed.
Key takeaways
- The proposed sensor stacks silicon dioxide and porous silicon around a central tissue-sensing defect layer.
- Simulations reported transmittance sensitivities up to 2.4 × 10^11 percent per refractive-index unit for frozen tissue models.
- The work does not establish performance in a fabricated device or diagnosis in patients.
A team has designed a terahertz sensor that uses a photonic crystal and parity-time symmetry to distinguish modeled healthy and cancerous oral tissues kept at −20 °C. In simulations, the design produced sharp transmission signals and high calculated sensitivity to changes in tissue refractive index. The work matters because it points to a possible label-free way to analyze frozen tissue, but it does not establish that a built device can diagnose cancer in clinical practice.
A crystal with a sensing pocket
The proposed sensor is a one-dimensional photonic crystal: a stack of alternating silicon dioxide and porous silicon layers. The layers form a filter for terahertz waves, much like a set of mirrors that reflects some frequencies while allowing others through. At the center, a defect layer interrupts the repeating pattern and holds the tissue sample.
The researchers modeled the device using a transfer matrix method, a mathematical approach for calculating how waves travel through layered materials. They used tissue refractive-index and absorption data from an earlier experimental dataset, covering frequencies from 0.2 to 1.1 terahertz at −20 °C. The model represents differences between healthy and cancerous tissue as changes in the terahertz wave’s behavior inside the sensing layer.
Using symmetry to sharpen the signal
The design adds parity-time symmetry, a way of pairing gain and loss in a system. In this case, the researchers incorporated layers with complex refractive-index values chosen to meet that symmetry condition. The calculations indicate that this arrangement creates sharper resonances, or distinct peaks in the transmitted signal, than a conventional photonic-crystal sensor.
Those peaks shift when the refractive index in the defect layer changes. The team reported transmittance-based sensitivities of 2.4 × 1011 and 1.7 × 1010 percent per refractive-index unit for Q settings of 10.695 and 7.85, respectively. For the same two settings, the reported frequency-based sensitivity was 68.8 gigahertz per refractive-index unit.
What the model suggests
The tissue data used in the analysis showed differences the sensor could potentially detect: across the modeled frequency range, healthy tissue had a higher refractive index and absorption than cancerous tissue. The calculations also indicated distinct defect-mode signals for both tissue types, addressing a challenge the researchers identify in some earlier parity-time designs, where one sample’s signal can become too weak to measure.
The structure uses a small number of repeated layers and materials the researchers describe as suitable for terahertz photonics. In the proposed arrangement, silicon dioxide provides a lower refractive index than porous silicon, helping create the frequency-selective response. The central defect layer is the part that interacts with the tissue sample.
Why This Matters
Separating healthy from cancerous tissue through a measurable optical signal could eventually support faster or less invasive tissue analysis. Here, however, the reported performance comes from mathematical simulations built around previously measured tissue properties. It does not show that a physical sensor has been fabricated, tested on patient samples, or validated as a diagnostic tool.
The next step is to test whether the modeled resonances hold up in a fabricated device and with real tissue specimens. Until then, the work is a proposed sensing design, not a demonstrated method for detecting oral cancer.
Topics: Cancer
Start here: Biosensors explained